Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind study of cefepime-zidebactam vs meropenem in adults with complicated urinary tract infection or acute pyelonephritis
CTR20222627Phase 3Active
- Sponsor
- Wockhardt
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cefepime + zidebactam in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Wockhardt. Started May 2024; status: active.
02
Drugs
cefepime + zidebactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20222627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222627.